Biotelemetry, inc. (BEAT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
OPERATING ACTIVITIES
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

25,268

29,844

38,661

46,379

48,523

41,874

14,980

-3,585

-12,303

-17,143

40,389

46,565

49,536

53,437

15,254

14,120

11,594

7,428

2,926

419

-5,740

-9,793

-8,116

-11,043

-9,354

-7,319

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Accounts Receivable, Credit Loss Expense (Reversal)

22,672

21,800

21,674

20,973

22,469

22,200

21,236

19,847

15,388

13,300

11,109

9,836

10,084

9,931

9,075

8,825

8,336

8,047

9,144

8,767

9,337

9,347

8,898

8,457

7,679

7,787

0

0

0

Depreciation and amortization

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

0

21,124

-

13,896

10,841

10,680

10,547

10,528

10,170

9,522

8,987

8,363

8,496

8,845

8,858

9,077

9,863

9,654

9,978

0

0

0

Amortization

-

-

-

-

-

-

-

0

13,550

-

6,291

4,016

4,016

3,700

3,455

3,289

3,280

3,501

4,068

4,018

3,904

3,692

3,008

2,706

2,409

2,340

0

0

0

Stock-based compensation

14,209

13,376

12,645

10,364

9,745

9,261

8,273

8,403

6,687

7,680

8,430

8,083

8,382

6,502

5,388

5,389

5,010

4,952

4,696

4,251

4,154

4,037

3,460

3,560

3,606

3,303

0

0

0

Equity method investment loss

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of debt discount

1,193

1,243

1,243

1,243

1,243

1,243

1,241

1,189

934

678

423

218

217

217

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Non-cash lease income

-

-

-

-

-

-

-

-

-

-

-

0

-154

-

-86

5

34

14

132

38

-241

-355

-541

-368

5

215

0

0

0

Deferred income taxes

12,880

7,385

6,876

2,944

-3,403

-2,294

2,464

2,789

6,378

6,050

-38,811

-37,694

-38,670

-38,141

92

-322

-9

245

574

493

518

-2,499

0

0

0

-

-

-

-

Change in fair value of acquisition-related contingent consideration

-520

-230

0

0

0

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash items

-2,187

-1,018

130

264

-850

-254

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Healthcare and other accounts receivable

55,765

55,027

41,553

32,806

33,574

35,742

34,868

30,754

21,734

15,455

9,730

10,121

13,048

8,707

9,247

9,528

7,663

7,677

8,396

9,225

10,732

12,795

12,056

9,019

7,244

4,597

0

0

0

Inventory

-1,344

-1,585

-2,397

-1,671

2,603

1,991

2,700

2,556

1,166

-665

-379

-878

-544

753

792

-42

-157

-188

249

237

53

-299

-1,167

-1,025

-460

-340

0

0

0

Prepaid expenses and other assets

-5,337

-1,742

1,908

1,549

-1,642

-3,517

-873

-1,295

-225

694

-1,210

1,730

790

1,050

1,495

280

217

3

876

148

322

128

-1,154

-1,775

73

637

0

0

0

Accounts payable

-1,334

5,551

3,295

8,179

9,457

3,760

1,509

-5,665

-6,454

-8,320

-6,513

-1,881

1,691

3,145

-1,083

-1,678

-1,584

-4,699

-2,233

-2,447

-2,922

47

-10

2,045

3,255

2,369

0

0

0

Accrued and other liabilities

-8,170

-3,681

-886

-3,105

-12,816

-8,826

-8,570

-11,638

-4,346

-1,464

-3,100

2,322

2,727

-456

2,068

-1,518

-1,519

-464

-445

-320

1,883

788

-1,976

-2,355

-3,129

-2,143

0

0

0

Net cash provided by operating activities

62,709

67,550

81,061

92,740

81,216

72,746

57,408

29,185

28,203

23,782

23,107

32,058

35,322

38,851

33,602

28,887

27,138

14,350

11,392

7,931

6,265

8,811

8,787

10,966

7,542

11,259

0

0

0

INVESTING ACTIVITIES
Liability associated with the Civil Investigative Demand

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,400

-6,400

-6,400

-3,100

6,400

0

0

0

-

-

-

-

Acquisition of business, net of cash acquired

200

44,766

48,516

48,516

48,316

3,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

14,100

0

0

0

-

-

-

-

Purchases of property and equipment and investment in internally developed software

32,357

30,707

30,825

30,792

26,033

24,637

19,255

17,437

14,668

13,697

14,332

11,404

10,353

10,899

11,797

12,623

15,041

13,600

13,114

11,840

10,994

12,781

13,283

12,354

10,189

8,169

0

0

0

Net cash used in investing activities

-32,557

-75,473

-79,805

-79,772

-74,813

-28,851

-14,690

-179,256

-178,159

-177,188

-189,700

-20,388

-35,635

-36,181

-29,767

-30,593

-15,041

-13,600

-13,114

-11,840

-19,394

-26,881

-27,383

-26,454

-15,889

-8,169

0

0

0

Proceeds related to the exercising of stock options and employee stock purchase plan

5,018

7,610

8,413

10,763

14,011

12,186

11,184

8,621

5,940

6,071

0

0

0

-

-

0

0

-

-

7

143

1,400

0

0

0

-

-

-

-

Payments of tax withholdings related to vesting of share-based awards

1,511

4,955

4,975

4,975

5,082

2,910

2,942

2,942

2,791

1,933

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on long-term debt

201,669

5,125

4,356

3,588

2,818

2,050

1,527

26,239

26,041

25,840

26,331

1,429

1,437

1,438

0

0

0

-

-

-

-

26,434

0

0

0

-

-

-

-

Proceeds from the exercise of employee stock options and employee stock purchase plan contributions

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Issuance of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41,838

0

0

0

-

-

-

-

Proceeds from borrowings on revolving credit facility

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of debt issuance costs

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on finance lease obligations

925

1,909

2,470

3,426

3,937

3,740

4,704

4,704

3,764

2,863

1,228

270

302

321

355

387

428

480

519

551

553

529

0

0

0

-

-

-

-

Acquisition of noncontrolling interests

-

-

-

-

-

2,885

7,650

7,650

7,650

4,765

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by/(used in) financing activities

31,235

-4,379

-3,388

-1,226

2,174

601

-5,533

162,873

161,481

166,457

160,576

-10,203

2,600

1,427

12,929

12,346

-1,549

-1,771

5,023

5,166

13,378

15,926

9,766

9,728

2,067

763

0

0

0

Effect of exchange rate changes on cash

-29

27

587

536

564

371

-309

-266

-277

-81

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect

61,358

-12,275

-1,545

12,278

9,141

44,867

36,876

12,536

11,248

12,970

-6,013

1,455

2,257

4,066

16,764

10,640

10,548

-1,021

3,301

1,257

249

-2,144

-8,830

-5,760

-6,280

3,853

0

0

0

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Non-cash purchases of property and equipment

5,763

3,302

1,170

1,019

2,648

505

1,056

1,131

441

498

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash fair value of equity issued for acquisition of business

-

-

-

-

-

0

0

117,440

119,412

117,440

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

7,883

8,029

8,307

8,488

8,445

7,836

7,365

6,915

5,075

3,888

2,661

1,267

1,241

1,273

1,303

1,339

1,371

1,044

1,001

845

852

856

0

0

0

-

-

-

0

Cash paid for taxes

-39

-89

260

-32

743

763

1,413

1,523

1,621

1,648

1,425

1,459

393

359

351

355

375

384

331

175

65

148

146

141

117

112

0

0

0